Log In
Print this Print this

BioChaperone Lispro

Also known as: BioChaperone Ultra fast-acting insulin analog

  Manage Alerts
Collapse Summary General Information
Company Adocia S.A.
DescriptionUltra-fast acting formulation of insulin lispro using BioChaperone polymer technology
Molecular Target Insulin receptor (INSR)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type I and Type II diabetes; Treat Type I diabetes
Regulatory Designation


Eli Lilly and Co.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today